Dr. Marc Lubin, from Rabin Medical Center’s Urology Department, came to New York for a one month observership in uro-oncology at Weill Cornell Medical Center.
During this time Dr. Lubin shadowed department head, Dr. Douglas Scherr, affording him direct access to one of the leading uro-oncologists, both at the clinic as well as during complex operative cases.
HOW THE RABIN MEDICAL EXCHANGE FELLOWSHIP EXPANDS A DOCTOR’S KNOWLEDGE
Studying the main urology textbooks and treatment guidelines forms the basis for every urologist's practice, but they don't provide the same insight gained through years of practice. Shadowing Dr. Scherr over an extended period gave me unique insight, not usually gained at the resident level, into his patient management dilemmas and decision-making process.
Seeing the similarities between Weill Cornell and our department at Rabin Medical Center served to strengthen my belief in our department as a world-leader. At the same time, I was able to identify specific differences in practice, some of which I intend to implement in our department at Rabin.
HOW AN INTERNATIONAL MEDICAL FELLOWSHIP IS VITAL TO THE FUTURE OF MEDICINE?
The insight gained from interacting with such a radically different environment (eg. private medical center vs. public health system, North American vs. Middle Eastern attitudes, different areas of focus within clinical research) can serve as the catalyst to new ideas to old problems.
DR. LUBIN’S POST RABIN MEDICAL EXCHANGE FELLOWSHIP PLANS:
As of July 1, 2017 I will be the Fellow for laparoscopic/robotic oncologic and reconstructive surgery in the Department of Urology at Mt Sinai Health System in New York City. Had I not participated in the observership, this fellowship would likely not have been possible. I will be forever grateful for the doors this observership has opened for me.
In September, 2015, at age 51, Melissa Arnold was
diagnosed with ovarian cancer. Her immediate
reaction was relief. She had felt awful for
months, with pain in her upper chest and
weird bloating in her stomach and legs.
A researcher at Zebra Medical Vision has created a new mammography algorithm that uses machine and deep learning to diagnose breast cancer (BC), with results that the company claims are superior to those achieved using current methods.